Clinical Trial Update: S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

National Cancer Institute conducted a Phase 2 trial of imatinib mesylate plus capecitabine in women with progressive stage IV breast cancer; the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Imatinib mesylate (Imatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-09